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Autophagy is an ancient biological process for maintaining cellular homeostasis by degra-
dation of long-lived cytosolic proteins and organelles. Recent studies demonstrated that
autophagy is availed by immune cells to regulate innate immunity. On the one hand, cells
exert direct effector function by degrading intracellular pathogens; on the other hand,
autophagy modulates pathogen recognition and downstream signaling for innate immune
responses. Pathogen recognition via pattern recognition receptors induces autophagy.The
function of phagocytic cells is enhanced by recruitment of autophagy-related proteins.
Moreover, autophagy acts as a delivery system for viral replication complexes to migrate to
the endosomal compartments where virus sensing occurs. In another case, key molecules
of the autophagic pathway have been found to negatively regulate immune signaling, thus
preventing aberrant activation of cytokine production and consequent immune responses.
In this review, we focus on the recent advances in the role of autophagy in pathogen
recognition and modulation of innate immune responses.
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INTRODUCTION
Eukaryotic cells contain two major protein degradation systems
for maintaining cellular homeostasis: the ubiquitin-proteasome
system, responsible for degradation of soluble short-lived pro-
teins (Kloetzel, 2001), and autophagy, a conserved system that
degrades long-lived proteins and organelles (Klionsky and Emr,
2000). Autophagy was originally described as a starvation-induced
response that provides nutrients by degrading long-lived proteins
and recycling intracellular organelles (Kuma et al., 2004; Komatsu
et al., 2005). There are three types of autophagy: microautophagy,
chaperone-mediated autophagy, andmacroautophagy (Figure 1A;
Mizushima and Klionsky, 2007). Macroautophagy is the main
route of degradation. It involves the formation of a double-
membrane vesicle called autophagosome, which is formed by
elongation of a cup-shaped membrane, followed by wrapping of
the cellular constituents and fusionwith lysosomes fordegradation
(Mizushima et al., 1998). The molecular mechanism underly-
ing autophagy has been thoroughly covered in excellent reviews
elsewhere (Klionsky and Emr, 2000; Ohsumi, 2001; Mizushima
et al., 2002). Here, we brieﬂy describe the process relevant to
innate pathogen recognition by macroautophagy. Autophagy-
related gene (Atg) 6 (Beclin-1) and type III phosphatidylinositol
3-kinase (PI3K) are required for the initiation of the isolation
membrane. The elongation and termination of the autophago-
some are regulated by at least two ubiquitin-like systems: the
microtubule-associated protein 1 light chain 3 (LC3; mammalian
homolog of the yeast autophagic protein Atg8) and the Atg12
conjugation pathways. The C-terminal amino acids of LC3 are
cleaved by Atg4, and this C-terminal residue then gets transferred
to phosphatidylethanolamine (PE) in the newly formed isolation
membrane by the E1- and E2-like enzymes Atg7 and Atg3, respec-
tively. Although LC3 gets recycled from the outer autophagosomal
membrane by deconjugation from its phospholipids, it remains
attached to the inner autophagosomal membrane, and this por-
tion is degraded along with the inner autophagosomal membrane
in lysosomes and late endosomes after fusion with these vesi-
cles (Ohsumi, 2001). Autophagosome-associated LC3 (LC3-II)
and free cytosolic LC3 (LC3-I) can be distinguished by their
apparent molecular weight, and autophagosomes can be visual-
ized by using green ﬂuorescent protein (GFP)-conjugated LC3
molecules. In the other ubiquitin-like system, Atg12 gets coupled
through its C-terminal glycine residue to a lysine residue of Atg5
by the E1- and E2-like enzymes Atg7 and Atg10, respectively. The
Atg12–Atg5 complex associates with Atg16 and then binds to the
outer surface of the isolation membrane. Upon completion of
the autophagosome, the Atg5–Atg12–Atg16 complex dissociates
from the outer autophagosomal membrane and only LC3 remains
associated with the completed autophagosome. Autophagosomes
then fuse with late endosomes and lysosomes for degradation of
their contents and membrane (Figure 1B; Levine and Deretic,
2007).
Besides maintaining cellular homeostasis, autophagy plays
important roles in multiple biological processes including devel-
opment, aging, anddegeneration (Levine andKlionsky,2004).Not
surprisingly, aberrant regulation of autophagy induces many dis-
eases such as cancer, neurodegenerative diseases, and myopathies
(Shintani and Klionsky, 2004; Levine and Kroemer, 2008).
Recently, autophagy was found to be involved in immunity. It
can act as a direct effector by eliminating invading pathogens
(Gutierrez et al., 2004; Nakagawa et al., 2004; Deretic, 2005; Ogawa
et al., 2005), regulating innate pathogen recognition (Sanjuan
et al., 2007; Xu et al., 2007; Delgado et al., 2008), contribut-
ing to antigen presentation via major histocompatibility complex
(MHC) class II molecules (Dengjel et al., 2005; Paludan et al.,
2005; Schmid and Munz, 2007; Schmid et al., 2007), and con-
trolling B- and T-cell development (Li et al., 2006; Pua and He,
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FIGURE 1 |Three types of autophagy and cellular and molecular events
in an autophagic pathway. (A)There are three types of autophagy. In
macroautophagy, which is the main route of cellular degradation, an
autophagosome (a double-layered membrane vesicle) is formed, which
fuses with lysosomes to degrade the cellular constituents or pathogens.
Microautophagy is characterized by the removal of cellular constituents via
the budding of an autophagic body at the lysosomal membrane. In
chaperone-mediated autophagy, a signaling motif that contains molecules
is transported with the chaperone HSC70 via the LAMP-2A protein into
lysosomes. (B)The autophagic pathway consists of three distinct stages.
For process initiation, nucleation of the autophagic vesicle is needed. Atg6
(Beclin-1) and type III PI3-kinase are required for the initiation of
isolation-membrane formation. Elongation and closure of the
autophagosome membrane are regulated by two ubiquitin-like conjugation
systems: LC3 and Atg12 conjugation systems. The autophagosome fuses
with lysosomes and subsequently matures into an autolysosome to
degrade the materials present inside the cell.
2007; Pua et al., 2007; Miller et al., 2008). In this review, we focus
on the role of autophagy in innate pathogen recognition and its
regulation.
AUTOPHAGY IN PATHOGEN RECOGNITION
PAMPs STIMULATING CERTAIN TLRs INDUCE AUTOPHAGY INDUCTION
The innate immune system recognizes only a limited number
of microbial molecular structures, so-called pathogen-associated
molecular patterns (PAMPs; Iwasaki and Medzhitov, 2004; Akira
et al., 2006),which are conservedwithin the same class of microbes
but differ across classes (e.g., viruses, Gram-negative bacteria,
Gram-positive bacteria, and fungi). Pattern recognition receptors
(PRRs) bind to these conserved structures and initiate down-
stream signaling pathways. PRRs are located in various sites such
as plasmamembranes, endosomal vesicles, and cytoplasm, thereby
enabling the recognition of various types of microbes in any
of these locations. Toll-like receptors (TLRs) are the most well-
known PRRs in innate pathogen recognition. TLRs can be divided
into two groups based on their locations: cell surface TLRs, TLRs
1, 2, 4, 5, and 6, that mainly recognize bacterial components, and
endosomal TLRs, TLRs 3, 7, 8, and 9, that generally recognize
viral nucleic acids. All these receptors contain leucine-rich repeats
(LRRs) in their extracellular domain for ligand binding, and a
cytoplasmic Toll/IL-1 receptor (TIR) homology domain, which
is essential for signaling. After recognition of PAMPs, TLRs ini-
tiate common or distinct signaling pathways via different kinds
of adaptor molecules. All TLRs except TLR3 activate the tran-
scription factors, nuclear factor (NF)-κB and activator protein-1
(AP-1), via MyD88, leading to the production of proinﬂamma-
tory cytokines. TLR3 and TLR4 activate the transcription factor
interferon regulatory factor 3 (IRF3) via TIR domain-containing,
adapter-inducing interferon-β (TRIF), leading to the produc-
tion of type I IFNs (Lee and Kim, 2007; Delgado and Deretic,
2009).
Recently, some studies have shown that activation of TLR can
lead to induction of autophagy (Xu et al., 2007; Delgado et al.,
2008; Shi and Kehrl, 2008). After stimulation with lipopolysac-
charide (LPS), TLR4 can induce autophagy in primary human
macrophages and in the murine macrophage cell line RAW264.7
(Xu et al., 2007). It was shown that LPS stimulation induces redis-
tribution of LC3 protein from a diffuse to a punctate pattern and
increases the levels of the lipidated form of LC3 (LC3-II), both
of which are reliable markers of autophagy induction. Interest-
ingly, this LPS-induced autophagy occurs via a TRIF-dependent,
MyD88-independent TLR signaling pathway, for which receptor-
interacting protein 1 (RIP1) and p38 mitogen-activated protein
kinase (MAPK) are required (Figure 2).Moreover, Xu et al. (2007)
also reported that LPS-induced autophagy results in mycobac-
terial colocalization with the autophagosomes, suggesting that
autophagy could enhance the elimination of mycobacteria. In
another study, mycobacteria elimination has been demonstrated
using starvation and rapamycin for autophagy induction(Gutier-
rez et al., 2004).
A study reporting the effect of TLR agonists on autophagy
induction in RAW264.7 macrophages (Delgado et al., 2008)
showed that ligands of TLR3, TLR4, and TLR7 could induce
autophagy, and those of TLR7 generated the most potent effects
(Figure 2). Two different ligands of mouse TLR7, single-stranded
RNA (ssRNA) and imiquimod, induced formation of autophago-
somes characterized by LC3 puncta formation in murine primary
macrophages (Delgado et al., 2008). Induction of autophagy via
TLR7 signaling was dependent on MyD88 and required Beclin-1.
Moreover, autophagy activation by TLR7 agonists induced killing
of intracellular mycobacteria, even though mycobacteria are nor-
mally not associated with TLR7 signaling. This ability of pathogen
eliminationwas diminished by siRNAknockdownof Beclin 1, thus
depending on autophagy.
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FIGURE 2 | Autophagy induction byTLR stimulation. Activation of TLR
can induce autophagy for pathogen elimination. Stimulation of TLR4 with
LPS in a TRIF-dependent, MyD88-independent signaling pathway, and
stimulation of endosomal TLR7 with two different TLR7 ligands via the
MyD88-dependent pathway induces autophagosome formation and
eliminates Mycobacteria bacilli, even though mycobacteria are normally not
associated with TLR7 signaling. Atg proteins such as Atg5, Beclin-1, and
PI3K are required for the formation of an autophagosome.
INTERPLAY BETWEEN AUTOPHAGY AND PHAGOCYTOSIS
Unlike TLR4- and TLR7-mediated induction of autophagy, which
enhances autophagosome fusion with the pathogen-containing
phagosomes and promotes elimination of intracellular pathogens,
certain TLR signaling pathways enhance thematuration of phago-
somes by the autophagic machinery (Sanjuan et al., 2007). Upon
phagocytosis of zymosan (a component of the fungal cell wall),
phagosomes rapidly recruit LC3 and fuse with lysosomes for
maturation (Figure 3). Pam3CSK4 coating of latex beads also
induces the rapid recruitment of LC3 to phagosomes in RAW264.7
macrophages. This zymosan-mediated translocation of LC3 to
phagosomes was found to be independent of MyD88 but depen-
dent on Atg5 and Atg7. Live Saccharomyces cerevisiae engulfed
by macrophages survived more frequently in Atg7 knockout
macrophages than in wild-type macrophages. Interestingly, LC3
recruitment to phagosomal membranes was not associated with
the double-membrane structures characteristic of autophago-
somes. Instead, it was associated with phagosome fusion with
lysosomes,which enhanced killing of the engulfed pathogens. Col-
lectively, this studyhas shownanewwayof utilizing the autophagic
machinery to promote conventional functions of phagocytes after
TLR activation, in the absence of autophagosome formation.
NOD-LIKE RECEPTOR SIGNALING AND AUTOPHAGY
To the best of our knowledge, there are only two reports on the
NOD-like receptor (NLR) family in autophagy (Cooney et al.,
2010; Travassos et al., 2010). NLRs recognize bacterial cell wall
FIGURE 3 | Interplay between autophagy and phagocytosis.TLR
signaling can enhance the maturation of phagosomes with the autophagic
machinery. LC3 recruitment to phagosomal membranes promotes the
fusion of phagosome with lysosome for maturation. However, LC3
recruitment to phagosomal membranes is not associated with the
characteristic double-membrane structure of the autophagosomes. The
Atg5 and Atg7 proteins are involved in the development of this structure.
components (speciﬁcally, peptidoglycans) in the eukaryotic cell’s
cytosol. NLRs are composed of three distinct domains: a C-
terminal LRR, a NACHT domain, and an N-terminal effector
domain, which mediate ligand sensing, activation of the NLRs,
and initiation of downstream signaling, respectively. When NLRs
recognize bacterial peptidoglycans, they initiate signaling trans-
duction by recruiting the protein kinases, which, in turn, acti-
vate NF-κB and AP-1 leading to production of cytokines and
other molecules involved in innate immunity (Lee and Kim,
2007).
Recent studies have shown that activation of NOD2 by
muramyl dipeptide (MDP) induces autophagosome formation,
which in turn enhances bacterial clearance (Figure 4; Kuma
et al., 2004; Travassos et al., 2010). In human DCs, NOD2
stimulated with MDP induces autophagosome formation, which
promotes MHC class II-associated antigen presentation. Atg5,
Atg7, Atg16L1, and receptor-interacting serine-threonine kinase-
2 (RIPK2), the latter being one of the downstream regulators
of the NOD2 signaling pathway, are required for autophago-
some formation and antigen presentation by MDP (Cooney et al.,
2010). Another study also showed that stimulation of NOD1 and
NOD2 by bacterial peptidoglycans activates the autophagy path-
way inmouse embryonic ﬁbroblasts (MEFs; Travassos et al., 2010).
Upon bacterial invasion, NOD2 recruits Atg16L1 to the bacterial
entry sites, facilitating bacterial trafﬁcking to the autophagosomes.
This, in turn, induces the fusion of the autophagosomes with the
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FIGURE 4 | NOD-like receptor-mediated autophagy induction. NOD-like
receptors recognize bacterial peptidoglycan in the cytosol. C-terminal
leucine-rich repeats (LRRs) of NOD1 and NOD2 detect
γ-d-glutamyl-meso-diaminopimelic acid (iE-DAP) and muramyl
dipeptide(MDP), respectively. NOD1 and NOD2 can induce the
autophagosome formation after stimulation with bacterial peptidoglycan,
which promotes bacterial clearance and MHC class II-associated antigen
presentation. This process depends on Atg5, Atg7, and Atg16L1.
lysosomes to form the autophagolysosomes and promotes antigen
presentation via MHC class II molecules. In MEFs, this process
does not require the adaptor RIP2 and the transcription factor
NF-κB. Interestingly,NOD2mutation and single-nucleotide poly-
morphism in the Atg16L1 gene have been known to be associated
with the development of Crohn’s disease (Cho and Weaver, 2007;
Hampe et al., 2007; Rioux et al., 2007). DCs isolated from patients
with Crohn’s disease and risk alleles for NOD2 orAtg16L1 showed
impaired function in autophagy induction and antigen presen-
tation (Cooney et al., 2010). Collectively, these reports revealed
a close relationship between two of the most important Crohn’s
disease-associated susceptibility genes. Furthermore, they func-
tionally link bacterial sensing by NOD proteins to the autophagy
pathway.
ROLE OF AUTOPHAGY IN VIRAL SENSING
In addition to the aforementioned direct effector function,
autophagy also works in TLR activation by delivering cytosolic
PAMPs to endosomal TLRs (Lee et al., 2007). In plasmacytoid
dendritic cells (pDCs), viral RNA or DNA recognized by TLR7
or TLR9, respectively, induces type I IFN and proinﬂammatory
cytokine production. These TLRs are located in the endosomal
compartment and sense the viral nucleic acids endocytosed by the
host cells (Barton, 2007). In addition to NF-κB andMAPK activa-
tion, MyD88, an adaptor molecule for these TLRs, activates IRF7,
leading to type I IFN production.
In the case of vesicular stomatitis virus (VSV), the replicating
virus rather than the viral genome is required to initiate TLR7 sig-
naling and produce IFN-α in pDCs. However, how these cytosolic
replication intermediates gain access to the endosomal compart-
ment where TLR7 resides is not completely known. A recent study
demonstrated that cytosolic PAMP is delivered by autophagy to
the lysosomes for TLR7 recognition (Figure 5; Lee et al., 2007).
Thus, Atg5-deﬁcient pDCs fail to sense VSV via TLR7, and are
unable to secrete IFN-α and IL-12p40. Consequently,mice lacking
Atg5 fail to defend themselves from systemicVSV infection in vivo.
Moreover, IFN-αproduction is impaired inAtg5-deﬁcient pDCs in
response to herpes simplex virus-1 (HSV-1), which is recognized
by TLR9,while IL-12 response remained intact in these cells. Thus,
autophagy plays a critical role in the induction of innate immune
responses by delivering viral replication intermediates from the
cytosol to the endosome for recognition after ssRNA virus infec-
tion (Lee and Iwasaki, 2008; Tal and Iwasaki, 2009; Yordy and
Iwasaki, 2011).
NEGATIVE REGULATION OF INNATE IMMUNE RESPONSES VIA
AUTOPHAGY
The autophagic machinery plays key roles other than activating
PRR signaling. In contrast to viral recognition in pDCs, which
is mediated by endosomal TLRs, most of the other cell types
utilize cytosolic sensors such as those encoded by retinoic acid-
inducible gene I (RIG-I ) andmelanoma differentiation associated
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FIGURE 5 | Role of autophagy in antiviral immune response.
Autophagy and Atg proteins are required for viral sensing and regulation of
antiviral immune responses. In pDCs, autophagy mediates the recognition
of viral infection by delivering the viral replication intermediates in the
cytosol to lysosomes, whereTLR recognition occurs, which, in turn,
enhances type I IFN production. However, in non-pDCs, such as mouse
embryonic ﬁbroblasts (MEFs), autophagy negatively regulates type I IFN
production in response to viral infection. Atg5-Atg12 conjugates block RLR
signaling by direct CARD-mediated association with RIG-I and IPS-1,
resulting in the suppression of type I IFN production. In the case of dsDNA
recognition, STING, a multispanning membrane protein, is translocated
from the ER to the Golgi apparatus and assembled with TBK1, which
phosphorylates the transcription factor IRF3, resulting in the production of
type I IFN. During this process, Atg9a, an essential component of
autophagy, colocalizes with STING in the Golgi apparatus, where it
controls the assembly of STING.
gene 5 (MDA-5) to detect the virus invasion (Yoneyama et al.,
2004, 2005; Foy et al., 2005). RIG-I andMDA-5, both of which are
RIG-I-like receptors (RLRs), contain a DExD/H box RNA heli-
case domain for ligand recognition and two caspase-recruiting
domains (CARDs) for initiating downstream signaling. When
these CARD-containing RNAhelicases recognize double-stranded
RNA (dsRNA), which is synthesized during active viral replication
in the cytosol, signals through IFN-β promoter stimulator-1 [IPS-
1; also known as mitochondrial antiviral signaling (MAVS), virus-
induced signaling adaptor (VISA), or Cardif] activate the tran-
scription factors IRF-3 and NF-κB, and subsequently lead to the
production of type I IFN. IPS-1 is an essential adaptor molecule
consisting of an N-terminal CARD domain (through which it
associates with RIG-I and MDA-5) and a C-terminal domain (for
mitochondrial localization; Lee and Kim, 2007).
A recent study revealed that Atg5–Atg12 conjugates, essential
components of the autophagic process, regulate innate viral recog-
nition by RIG-I and MDA-5 in MEFs (Figure 5; Jounai et al.,
2007). Atg5- and Atg7-deﬁcient MEFs, lacking Atg5–Atg12 con-
jugates, overproduce type I IFN in response to VSV. Conversely,
biochemical analysis indicated that Atg5–Agt12 conjugates block
RLR signaling by direct CARD-mediated association with RIG-
I and IPS-1; additionally, they suppress type I IFN production.
Thus, autophagy-related proteins involved in RLR-mediated viral
sensing repress type I IFN response, acting as negative regulators
of antiviral responses.
Similarly, in another report, Atg5-deﬁcient cells showed over-
production of type I IFN through enhanced RLR signaling path-
way (Tal et al., 2009). That study also showed that dysfunctional
mitochondria and mitochondria-associated IPS-1 were accumu-
lated in the absence of autophagy. In Atg5-deﬁcient cells, reactive
oxygen species associated with dysfunctional mitochondria may
potentiate RLR signaling, which can be blocked by antioxidant
treatment. Thus, autophagy plays important roles in the balanced
regulation of innate antiviral response by acting as a scavenger of
dysfunctional mitochondria.
Another recent study showed that Atg16L1, a candidate gene
for Crohn’s disease, is involved in endotoxin-induced inﬂamma-
some activation in mice (Figure 6A; Saitoh et al., 2008). Atg16L1
is an essential component of the autophagosome. It forms a
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FIGURE 6 | Suppression of inflammasome activity by autophagy. (A)
Atg16L1, a candidate gene for Crohn’s disease, regulates endotoxin-induced
inﬂammasome activation. Atg16L1-deﬁcient macrophages exhibit enhanced
IL-1β and IL-18 production in response to LPS. This process is mediated by
excessive ROS, which activates caspase-1, leading to the processing of IL-1β.
(B) Autophagy limits IL-1β production by eliminating active inﬂammasomes.
Induction of AIM2 or NLRP3 inﬂammasomes triggers the nucleotide
exchange of RalB, which promotes autophagosome formation by the binding
activated RalB to the exocyst complex subunit Exo84.This binding induces the
assembly of active kinase complexes on the exocyst, which are required for
the formation and maturation of isolation membranes into autophagosomes.
Activation of inﬂammasomes leads to the ubiquitination of ASC, and
ubiquitinated inﬂammasomes are engulfed by autophagosomes via the
autophagic adaptor protein, p62.
complex with Atg5–Atg12 conjugates and induces LC3-PE conju-
gation (Fujita et al., 2008). Atg16L1-deﬁcientmacrophages exhibit
enhanced IL-1β and IL-18 production in response to LPS. This
process is mediated by TRIF-dependent activation of caspase-1,
which, in turn, activates IL-1β production.Moreover,mice lacking
Atg16L1 in hematopoietic cells are highly susceptible to dextran
sulfate sodium-induced acute colitis, which is alleviated by the
injection of anti-IL-1β and IL-18 antibodies (Saitoh et al., 2008).
Hence, Atg16L1 plays an important role in negatively regulating
endotoxin-induced inﬂammatory immune responses.
Very recently, an interesting study showed the relationship
between autophagy and inﬂammasome activity. This study sug-
gested that autophagy induced by inﬂammatory signals targets
ubiquitinated inﬂammasomes for destruction, thereby limiting
IL-1β production (Figure 6B; Shi et al., 2012). The activation
of AIM2 or NLRP3 inﬂammasomes in macrophages triggers
nucleotide exchange on RalB, thereby effecting autophagosome
assembly (Bodemann et al., 2011; Shi et al., 2012). Autophagic
adaptors such as p62 (sequestosome 1) and neighbor of BRCA1
gene (NBR1), which have ubiquitin-associated (UBA) domains
and LC3-interacting regions (LIR), recognize ubiquitinated mol-
ecules and facilitate their elimination by autophagy (Johansen
and Lamark, 2011; Deretic, 2012). Various kinds of intracellular
pathogens are recognized by different kinds of autophagic adap-
tors and thereby eliminated by autophagy (Dupont et al., 2009;
Zheng et al., 2009; Orvedahl et al., 2010; Mostowy et al., 2011).
Similarly, in the present study, assembled inﬂammasomes were
ubiquitinated, and these ubiquitinated complexes were recruited
by the autophagic adaptor p62, which assisted in their entry into
the autophagy pathway. Thus, autophagy limits inﬂammasome
activity by eliminating active inﬂammasomes, and this tempers
inﬂammation.
The exact mechanisms underlying recognition of dsDNA
derived from bacteria or DNA viruses are still unclear, and so are
the subsequent immune responses.Nonetheless, it becomes appar-
ent that stimulation with dsDNA induces the production of type I
IFNs and other inﬂammatory cytokines (Stetson and Medzhitov,
2006; Charrel-Dennis et al., 2008). Recent studies indicated that
translocation and assembly of stimulator of IFN genes (STING)
andTANK-binding kinase 1 (TBK1) are required for the induction
of type I IFN responses (Ishikawa and Barber, 2008; Jin et al., 2008;
Zhong et al., 2008; Sun et al., 2009). STING is a multispanning
membrane protein, which is translocated from the endoplasmic
reticulum to the Golgi apparatus after sensing dsDNA, followed
by assembly with TBK1, which phosphorylates the transcription
factor IRF3, leading to the production of type I IFNs. During
this process, Atg9a colocalizes with STING in the Golgi appara-
tus, where it controls the assembly of STING (Saitoh et al., 2009).
In Atg9a-deﬁcient MEFs, but not in Atg7- and Atg16L1-deﬁcient
MEFs, the translocation of STING from the Golgi apparatus to
the cytoplasmic punctate structures, and its assembly with TBK1,
are greatly enhanced. This, in turn, induces aberrant activation of
type I IFN responses (Saitoh and Akira, 2010). Overall, these ﬁnd-
ings underline a role for Atg9a in the regulation of innate immune
responses.
CONCLUSIONS
Recent studies have demonstrated that autophagy acts as an
important regulator of immune responses. In addition to elim-
ination of intracellular pathogens by its original function of
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degradation (xenophagy), autophagy can be involved in innate
pathogen recognition and modulate the downstream signaling
pathway.Autophagypromotes the clearanceof cytosolic pathogens
via autophagosome formation, which is elicited by TLR sens-
ing. Autophagic machinery is utilized to enhance phagosome–
lysosome fusion and efﬁciently eliminate extracellular phago-
cytosed pathogens. Moreover, autophagy can promote adaptive
immune responses such asMHCclass II-restricted antigen presen-
tation after bacterial sensing via NLRs. In case of viral recognition,
autophagy delivers the cytosolic replication intermediates to the
lysosomes, where recognition by the endosomal TLRs occurs, thus
enhancing the production of type I IFN essential for antiviral
response. However, autophagy does not play a role in enhanc-
ing pathogen elimination alone. It can also negatively regulate the
signaling pathway mediating pathogen recognition and elimina-
tion. In case of viral recognition by cytosolic viral sensors such as
RLRs, autophagy represses the signaling downstream of the innate
immune response, such as that mediating the production of type
I IFN. Autophagy-related proteins, including Atg16L1, are also
involved in the regulation of endotoxin-induced inﬂammasome
activation, which has been associated with Crohn’s disease. Recent
advances in the study of autophagy have largely helped under-
standing the mode of function of the autophagic machinery in
PRR-mediated innate pathogen recognition and its regulation.
Considering the complexity of autophagy function in immunity,
it is still unclear whether activation or suppression of autophagy
could have therapeutic beneﬁts in the treatment of infectious
diseases or inﬂammatory disorders such as Crohn’s disease. A bet-
ter understanding of the modulation of the immune system by
autophagy is essential to unveil new therapeutic avenues in the
future.
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